"Milk Thistle"[Mesh] OR "Silymarin"[Mesh] AND ("humans"[MeSH Terms] AND (Meta-Analysis[ptyp] OR Review[ptyp]) OR systematic[sb] AND English[lang] AND "2010/07/03"[PDAT] : "2015/07/03"[PDAT]) - Search Results

Year	Number of Results
2010	2
2011	4
2012	10
2013	15
2014	6
2015	6
2024	0

1

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F. Abenavoli L, et al. Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Phytother Res. 2010. PMID: 20564545 Review.

2

Silymarin and hepatocellular carcinoma: a systematic, comprehensive, and critical review.

Mastron JK, Siveen KS, Sethi G, Bishayee A. Mastron JK, et al. Anticancer Drugs. 2015 Jun;26(5):475-86. doi: 10.1097/CAD.0000000000000211. Anticancer Drugs. 2015. PMID: 25603021 Review.

3

Meta-analysis: silymarin and its combination therapy for the treatment of chronic hepatitis B.

Wei F, Liu SK, Liu XY, Li ZJ, Li B, Zhou YL, Zhang HY, Li YW. Wei F, et al. Eur J Clin Microbiol Infect Dis. 2013 May;32(5):657-69. doi: 10.1007/s10096-012-1789-1. Epub 2012 Dec 18. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23247631 Review.

4

Silymarin and its constituents in cardiac preconditioning.

Zholobenko A, Modriansky M. Zholobenko A, et al. Fitoterapia. 2014 Sep;97:122-32. doi: 10.1016/j.fitote.2014.05.016. Epub 2014 May 29. Fitoterapia. 2014. PMID: 24879900 Free article. Review.

5

Milk thistle: a future potential anti-osteoporotic and fracture healing agent.

Mohd Fozi NF, Mazlan M, Shuid AN, Isa Naina M. Mohd Fozi NF, et al. Curr Drug Targets. 2013 Dec;14(14):1659-66. doi: 10.2174/13894501113146660222. Curr Drug Targets. 2013. PMID: 24093748 Review.

6

Reassessing bioavailability of silymarin.

Javed S, Kohli K, Ali M. Javed S, et al. Altern Med Rev. 2011 Sep;16(3):239-49. Altern Med Rev. 2011. PMID: 21951025 Review.

7

Silybum marianum: Beyond Hepatoprotection.

Bahmani M, Shirzad H, Rafieian S, Rafieian-Kopaei M. Bahmani M, et al. J Evid Based Complementary Altern Med. 2015 Oct;20(4):292-301. doi: 10.1177/2156587215571116. Epub 2015 Feb 16. J Evid Based Complementary Altern Med. 2015. PMID: 25686616 Review.

8

Silymarin in the prevention and treatment of liver diseases and primary liver cancer.

Féher J, Lengyel G. Féher J, et al. Curr Pharm Biotechnol. 2012 Jan;13(1):210-7. doi: 10.2174/138920112798868818. Curr Pharm Biotechnol. 2012. PMID: 21466434 Review.

9

Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.

Moayedi Esfahani BA, Reisi N, Mirmoghtadaei M. Moayedi Esfahani BA, et al. Hemoglobin. 2015;39(2):75-80. doi: 10.3109/03630269.2014.1003224. Epub 2015 Feb 3. Hemoglobin. 2015. PMID: 25643967 Review.

10

The therapeutic potential of milk thistle in diabetes.

Kazazis CE, Evangelopoulos AA, Kollas A, Vallianou NG. Kazazis CE, et al. Rev Diabet Stud. 2014 Summer;11(2):167-74. doi: 10.1900/RDS.2014.11.167. Epub 2014 Aug 10. Rev Diabet Stud. 2014. PMID: 25396404 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

39 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year